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molecules with a diameter ranging from 10-100 nm. Nanotechnology has promising biomedical applications and most noteworthy 
amongst them are noble metal particles. For instance, gold nanoparticles (AuNPs) provide a unique blend of physical and optical 
properties, chemical inertness, and high surface to volume ratio. They can be synthesized as well as functionalised to support 
various ligands on their surface. Their surface functionalization and diverse properties render the gold nanoparticles highly useful 
for drug delivery and gene carrier for therapeutic purposes and as molecular probes for disease diagnosis. The foundation for the 
usage of AuNPs in therapeutics and diagnosis was laid by the ancient studies done with ruby gold for curing diseases in middle 
ages. Presently, AuNPs have become available in different types such as spheres, rods, shells, cages and SERS particles which 
vary in shape, size and physical properties. The biomedical applications of these particles include drug and gene delivery, cancer 
diagnosis and therapy, determination of biological molecules and microorganisms, detection of disease etiology, immunoassay, 
enzyme immobilization, etc. Overall, the focus of this review is to highlight that AuNPs provide an excellent platform for the 
discovery of new therapies, cure for certain cancers, molecular probe for diagnostic purposes, as well as gene carriers and drug 
delivery vehicles. Biomed Rev 2015; 26: 23-36.
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INTRODUCTION
the nanometer sized entities ranging from 10-100 nm (1), and 
application of devices, structures and systems by controlling 
like chemistry, physics, material sciences, molecular biology, 
and medicine. Recently, potential uses of nanomaterials 
have attracted ample amount of attention of basic and 
applied scientists (2, 5, 7, 8). Although the nanoparticles 
size ranges from one to several hundred of nanometers, they 
are comparatively smaller than large biomolecules such as 
antibodies, enzymes and receptors as well as neurons and 
red blood cells (1, 2-8). The nano-sized particles have unique 
optical, magnetic, electronic and structural properties (9). This 
property makes the nanoparticles highly promising for a wide 
range of biomedical applications such as molecular diagnosis, 
cellular imaging and targeted drug delivery depending upon 
the composite shape or structure of the nanoparticles (10). 
The well-studied nanoparticles include carbon nanotubes, 
liposomes, quantum dots, magnetic nanoparticles, polymeric 
particles and metallic nanoparticles (7, 11).  Namely, the 
unique and distinctive characteristics of nanoparticles 
are: (a) small size which ranges from 1-100 nm, (b) large 
surface-to-volume ratio, (c) shape, size and composition 
which determines the physical and chemical properties, (d) 
qualitative and quantitative target-binding properties, and (e) 
some nanostructures show high robustness (3).
The applications of metal nanoparticles in medicine and 
biomedical research are rather a new phenomenon and an 
overwhelming number of publications have appeared in 
the world literature during the past 10 years. A few unique 
properties of nanoparticles are their high reactivity towards the 
living cells, stability at high temperatures, and translocation 
into the cell organelles. These particles also demonstrate unique 
optical properties which make them capable of producing 
quantum effects suitable for imaging. These characteristics 
of nanoparticles make them highly useful in diagnostics and 
therapeutics. Among all the metal nanoparticles, the most 
commonly studied are gold, silver, iron, and titanium oxide 
nanoparticles (9). 
Gold nanoparticles were used by the Romans for the 
purpose of decorating and staining of glass. It is nearly 150 
years ago when Michael Faraday noticed that the properties 
of colloidal gold solution were different from that of bulk 
metalic gold. Over the last half-century, different high yielding 
techniques for the synthesis of gold nanoparticles (AuNPs, 
nanogold), including spherical and non-spherical shapes have 
been developed (12).
The AuNPs are biocompatible and non-toxic which makes 
them more advantageous over other metal nanoparticles. They 
have physico-chemical inertness, and are easy to synthesize 
and fabricate. The AuNPs exhibits optical properties related to 
plasmon resonance as well as functionalisation with molecular 
probes. These unique physico-chemical properties make 
them compatible for broad range of biomedical applications. 
Presently, the biomedical applications of AuNPs have expanded 
control, targeted drug delivery, optical imaging, biosensors, 
immunoassays, monitoring of biological activity of cells and 
tissues, exploiting resonance scattering, photo-thermolysis of 
cancer cells, and in vivo photo-acoustic techniques (9, 12, 13). 
HISTORICAL PERSPECTIVE OF GOLD NANOPARTICLES 
Metallic gold has a melting point of 1064°C and a boiling 
point of 280°C. This precious metal does not react with water 
or oxygen and is an excellent conductor of electricity (14). In 
1857, Michael Faraday explored the ruby gold nanoparticles 
and was astonished by the ruby color of the colloidal particles. 
His studies on the Au particles led to the birth of the modern 
day colloidal chemistry and the foundation of nanotechnology. 
Faraday observed that metallic Au was dispersed uniformly 
physico-chemical characteristics. Some 100 years later these 
ruby-colored colloids were found to be stable and their size 
was determined with the aid of electron microscope to be in 
ranges of 2-6 nm (15, 16).
Zsigmondy who started to investigate upon the opacity 
and color of the ruby glass, tried to reproduce Au colloids 
through different methods. He combined Faraday’s work 
and introduced a new procedure called, ‘seed mediated 
method’. This method is still being used for the synthesis of 
nanoparticles. He also came up with an ultra-microscope for 
characterization of size, shape and structure of nanoparticles. 
Another scientist, Svedberg introduced ultracentrifuge and 
through it demonstrated the dependence of the motion of 
macromolecules (colloids) on their shape and size (15).
In the middle ages, colloidal gold was used for curing wide 
variety of diseases such as arthritis, heart disorders, epilepsy, 
dysentery, venereal diseases and tumors and also for the 
diagnosis of syphilis, a method which was used until the 20th 
century. Towards the end of 16th century, colloidal gold was 
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routinely used to make ruby glass and for coloring ceramics 
by techniques which are still used for such purpose (14).
SYNTHESIS OF GOLD COLLOIDS
studied, followed by the rest of the subtypes. Based upon 
shape, size and physical properties the AuNPs are categorised 
into different subtypes: nanospheres, nanorods, nanoshells and 
nanocages Also, AuNPs which have great surface-enhanced 
Raman-scattering properties are called “SERS nanoparticles” 
(1, 13, 15). (Fig. 1)
GOLD NANOSPHERES 
It was proposed a method for the synthesis of gold nanospheres 
of 2 nm to 100 nm diameter which was based on the reduction 
of aqueous tetrachloroauric acid (HAuCl4) with sodium citrate 
in water at 90-100°C. The reducing agent and the experimental 
condition can be varied as desired. As this procedure is 
reasonably simple and environmentally friendly, it is the most 
commonly used method for the synthesis of nanospheres. By 
varying the molar citrate:gold ratio, the size of the nanospheres 
can be restrained (1, 14, 16, 17). Usually, small amounts 
of citrate will generate larger nanospheres (1, 14). The 
nanospheres obtained through this process generally have a 
broad distribution of size and shape. Mostly, the nanoparticles 
produced fall in the size range of 12- 60 nm with a relative size 
distribution of 10-15% and show a non-uniform and irregular 
shape such as ellipsoids, quasi-spheres, and triangles (16). 
However, this method has limitation of restricted use of water 
as the solvent and low yield (1, 14). 
A second method known as ‘Burst method’ is capable of 
producing thermally and air stable nanospheres which are more 
mono-dispersed and their size can be controlled up to < 10 nm 
of diameter (1, 14, 17). In this method, AuCl4
- is transferred 
using a phase transfer reagent tetraoctylammonium bromide 
from the aqueous solution to toluene and then reduced in the 
presence of dodecanethiol (C12 H25SH) with aqueous sodium 
borohydride. The ratio of thiol: gold controls the size outcome 
of the nanospheres (16). A larger thiol:gold ratio and the faster 
addition of the reducing agent under cold conditions will 
produce smaller and more mono-dispersed nanospheres (1, 14). 
GOLD NANORODS
There is a wide variety of strategies proposed for the synthesis 
of Au-nanorods. The most commonly used method for 
production of Au-nanorods is the ‘Seed-mediated synthesis’. 
The chemical reduction of gold salt takes place in the 
presence of a strong reducing agent like sodium borohydride 
(NaBH4) forming gold seeds. Then, these seeds are added to 
a gold salt solution containing a weak reducing agent such 
as hexadecyltrimethylammonium bromide and ascorbic 
acid for continuation of growth. The Au seeds formed in the 
solution with strong reducing agent acts as site for nucleation 
for formation of nanorods (1, 14, 17-19). The ratio of gold 
seeds:gold precursor is important for controlling the length 
to width ratio of the nanorods (20, 21). Furthermore, with the 
addition of AgNO3 to the solution, the yield could be greatly 
increased (22). The electrochemical deposition of gold into 
pores of the nanoporous polycarbamate or alumina template 
membranes is an emblematic method of synthesis of nanorods. 
This method is called ‘template method’. The pore diameter of 
the template membrane is the pre-determinant for the nanorod 
diameter, while the amount of gold deposited within the 
membrane pores is the pre-determinant for the nanorod length. 
A low yield due to formation of only a single monolayer of the 
Au-nanorods is a fundamental disadvantage of this method. 
Apart from the above described methods, several other 
procedures: namely growth of nanorods on mica surface, 
Figure 1. Schematic illustrations of different types of gold nanoparticles.
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bio-reduction, and photochemical synthesis as well as 
electrochemical synthesis for the growth and fabrication of 
nanorods have been explored (1, 14). 
GOLD NANOSHELLS
Gold nanoshells are a type of spherical nanoparticle which 
consists of a dielectric core of materials such as silica, 
polystyrene or sodium sulphide coated by a thin layer of metal 
(usually Au) (8, 23). Silica cores are grown by the reduction 
of tetraethyl orthosilicate in ethanol through the process 
developed by Stöber. The silica nanoparticles are coated with 
gold by using a seeded growth technique. An amine-terminated 
silane is used as a liner molecule for the attachment of small 
gold nanospheres of diameter 2-4 nm to the silica core. This 
allows the additional gold molecules to be reduced until the 
seed particles are consolidated into a complete shell. The 
diameter of the silica core and the amount if gold deposited 
on the surface of the core determines the diameter of the gold 
nanoshell and the shell thickness, respectively. Other methods 
of production of gold nanoshell are being continuously 
investigated. The thermo-sensitive core-shell particles can be 
used as the template for in situ synthesis.  For controlling the 
of particle aggregation, the micro-gel can be used as core 
material (1, 14, 19, 23). 
GOLD NANOCAGES
Gold nanocages containing controlled pore size on their 
surface were synthesized in 2006 by the galavanic replacement 
reaction between aqueous HAuCl4 and truncated- silver 
nanocubes. The silver nanostructures can be developed by 
polyol reduction, in which AgNO3 is reduced by ethylene 
glycol to develop silver atoms and then nanocrystals or 
seeds. The morphology of nanocrystals can be controlled by 
experimental conditions. Through the addition of more silver 
atoms the desired seeds can be produced. This can be done 
by controlling the silver seed crystalline structures in the 
presence of poly-(vinylpyrrolidone). Poly-(vinylpyyrolidone) 
is a polymer capable of selectively binding to the surface (14, 
19, 24). 
The galvanic replacement process is used to remodel the 
silver nanostructures into internal hollow space within Au 
synthesis of Au nanocages (1, 9). The dimension and wall 
thickness of the resultant Au nanocages can be precisely 
controlled by adjusting the molar ratio of silver : HAuCl4 (1). 
Au nanocages may provide some major advantages such as: 
(i) their surface plasmon resonance peaks could be adjusted 
by changing the ratio of Ag nanocubes : HAuCl4. Thus, 
covering the entire spectral region from 500 to 1200 nm, (ii) 
the number of truncated corners and void sizes, (iii) the Au 
nanocages could still show resonance peaks in the near-IR 
region with remarkably small size of about 50 nm, and (iv) 
employed in various biomedical applications (14).
SURFACE ENHANCED RAMAN SCATTERING NANOPARTICLES
Surface enhanced Raman scattering (SERS) is a technique in 
which the nanoparticles are labeled with groups having activity 
in the Raman spectral region. In 2002, a new method was 
reported in which gold nanospheres of diameter ~13 nm were 
strands were used as probes. Also, in one study conducted in 
2008, gold nanospheres of diameter ~60 nm were encased 
with a Raman reporter and then stabilized with a layer of 
thiolated polyethylene glycol. This technique appears to 
have more merits than that of other conventional ones, such 
sensitivity, robustness, superior performance in blood, high 
levels of multiplexing and other biological matrices (13-15). 
Cellular uptake and fate of gold nanoparticles
Cellular uptake of nanoparticles is mainly through endocytosis. 
For nanostructures, it is considered to be via receptor-mediated 
endocytosis involving an interaction between cell membrane 
receptors and ligands on the surface of the NPs (30). The 
cellular uptake and the intracellular fate of the nanoparticles 
largely depend on size, surface functionality, shape, charge 
and hydrophobicity (25, 30). The optimal sized nanoparticles 
have smallest internalization time. The particles of diameter 
20-50 nm have most efficient uptake while apoptosis is 
enhanced in 40-50 nm range. The variation in curvature of the 
AuNPs is the reason for shape dependent uptake, rod-shaped 
AuNPs have lower uptake than their spherical counterparts. 
than that for neutral and negatively charged AuNPs (26-29). In 
depth understanding regarding the uptake and accumulation of 
nanoparticles in living systems is vital for the successful usage 
the surface charge of the carrier and hydrodynamic radius of 
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nanoparticles. The route of administration also determines the 
biodistribution of nanoparticles. Generally, the nanoparticles 
have a more prolonged retention in the lymph nodes, in 
comparison to delivery via intramuscular, subcutaneous or 
topical routes (31). 
BIOMEDICAL APPLICATIONS OF GOLD NANOPARTICLES
As a Drug Delivery System
of a wide variety of pharmaceutical payloads, including small 
drug molecules or large biomolecules such as proteins and 
genetic materials. DDSs provide the positive characteristics to 
the ‘free’ payload through enhancing solubility, biodistribution, 
in vivo stability and pharmacokinetic properties. DDSs can 
cell type, providing a targeted drug delivery system (32-37). 
Furthermore, they can be loaded with huge amounts of drugs 
to act as reservoirs, rendering controlled and sustained release 
of drugs to maintain the levels within the therapeutic window 
(32, 33). The AuNPs have been effectively utilised as a drug 
delivery system. The transport and release factors play a 
critical role in the effectiveness of a drug delivery system. 
The drug can be loaded onto the nanosystem in two ways, 
either by covalent conjugation or non-covalent conjugation. 
Covalent conjugation usually requires intracellular processing 
of a pro-drug, whereas non-covalent conjugation employs 
active drug itself (9,25). Out of the several approaches used 
for fabrication of the AuNPs, the most common ones that are 
employed for targeted delivery applications includes surface 
functional groups (e.g. amine, carboxyl and thiol groups). 
Another approach is drug encapsulation on AuNPs using layer-
by-layer (LbL) conjugation. These complexes provide better 
protection of the encapsulated drug from enzymatic metabolic 
degradation, allowing prolonged half-life (t1/2) and improved 
of layers. Further, the delivery to a target cell can be achieved 
AuNP surface (38).
For therapy, the release of drug molecule from nanoparticle 
is a prerequisite and can be triggered by internal (e.g. pH or 
glutathione, GSH) or external (light) stimuli. Internal stimulus 
controls the release in a biological manner whereas external 
stimulus has a spatio-temporal control over the release (16, 
39). The release in case of covalent conjugation is well 
controlled, while drug molecules that are non-covalently 
conjugated suffer non-specific release or other types of 
interactions. Endogenously triggered release of AuNPs is 
based on glutathione (GSH) concentration in the plasma or 
across the cell membrane (9, 16). There exists a substantially 
higher intracellular GSH concentration (1-10 mM) compared 
to the extracellular thiol concentration (GSH 2µM, cysteine 
8µM) and this higher intercellular concentration is exploited 
by the GSH-mediated DDS. The pro-drug bound to the 
AuNPs can be either released via place-exchange reactions 
or via disulphide exchange. Moreover, surface cysteine of 
exchange, resulting in protein carrier conjugates which can 
alter bioavailability and pharmacokinetic properties (3, 16, 
39-41). The monolayer of the nanoparticles can provide 
steric shielding against this interaction, hence enabling 
their use in vivo. Externally controlled release of payload 
is a corresponding tool for site and time dependent delivery 
(40, 41). The IR radiation triggers local heating of the metal 
nanoparticles which can result in the controlled release of 
the therapeutic agents or dyes bound to the particles. When 
there is adsorption of the molecule onto the surface of the 
nanoparticle, the temperature increase would often result 
in desorption of the less stably conjugated molecule. This 
property of metal nanoparticles can be utilized in development 
of light regulated photothermal release system. These systems 
can be of two types: (i) direct desorption of the payload, and 
(ii) use of a thermally responsible polymer for triggering the 
release (16, 17). 
Application of AuNPs for gene delivery 
Gene therapy is envisioned an excellent approach for the 
treatment of acquired and genetic diseases. Induction of target 
gene expression and protein synthesis can be achieved by use 
of DNA or RNA vectors (25). Viral and non-viral systems have 
been most frequently used for gene delivery. However, the viral 
and non-viral systems have limitation for causing immune 
nanoparticles are considered suitable candidates for gene 
delivery, since they not only provide a high surface-to-volume 
ratio but also have a small size that maximises payload to 
carrier ratio (38, 39).
With PEGylated AuNPs, gene expression is enhanced by 
about 100-folds as compared to naked DNA (9, 42-47). This 
is so because the PEGylation under the normal cell culture 
conditions stabilizes the AuNP/DNA complex by providing it 
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with a protective layer for a longer time period. This procedure 
helps to increase transgene expression and reduces cytotoxicity 
(38). These functionalized nanoparticles are also used for the 
delivery of amino acids and small interfering RNA (siRNA) (9, 
42-49). It has been reported that mixed monolayer protected 
gold clusters (MMPCs) functionalized to amine containing 
alkyl chain exhibit effective intracellular plasmid DNA 
delivery and induction of target protein synthesis. The in vivo 
gene transfection was determined by charge density of MMPCs 
and alkyl chain length used in fabrication, whereas the protein 
induction was ascertained by MMPCs to pDNA ratio. The 
monolayer coverage of MMPCs and MPCs allow regulation 
of hydrophobicity and charge to maximize transfection 
superior transfection vector is provided by the amphiphilic 
particles which demonstrate that the hydrophobicity of 
or the consequent release of the DNA from endosomal vesicles 
(39). AuNPs functionalized with polyethyleneimine (PEI) and 
delivery, so these are used as a delivery vector with reduced 
toxicity in rabbit cornea (9, 48, 49).
The siRNA delivery extensively exploits the use of AuNPs 
contain a functional thiol group for extensive immobilization 
thiol interactions exhibited a strong adsorption on the surface 
of AuNPs. When this nanocomplex is transported into the 
cell, free siRNA is released by the reductive cytoplasmic 
addition, the end-functionalized siRNA can also be coupled to 
the polymer coated AuNPs through chemical linkages. Acid-
liable or reducible bonds can be used for selective delivery of 
conjugated siRNAs under acid-pH or reductive environment 
of the cells (38). 
The photo-cleavable linkers are also used for the delivery 
of adsorbed genetic material. The property of AuNPs heating 
on absorption of IR radiation is utilized for cleavage of the 
sensitive linkers. A photoliable nanoparticle was designed 
to convert the nature of surface from cationic to anionic 
upon irradiation. The particles were designed to have a 
photo-cleavable o-nitrobenzyl ester moiety and a quaternary 
ammonium salt as the end group. On irradiation, the linker 
cleaves to create an anionic carboxylate group and releases 
the DNA (39).
Application of AuNPs for chemical drug delivery
AuNPs are functionalized with various chemical drug 
and bacterial cells. Several of the anticancer drugs such as 
methotrexate, adriamycin, paclitaxel and doxorubicin have 
been studied for delivery through AuNP conjugation (3, 28). 
for anticancer therapy through the usage of nanoparticles. In 
the nanoparticle delivery system containing a PEG coated 
maximal tumor damage and minimal cytotoxicity. Also, the 
nanoparticles based delivery coupled with local heating results 
AuNPs having high surface to volume ratio, inherent low 
toxicity, and sustainable stability provide them with qualities 
suitable for the design of new drug delivery strategies. The 
optimization of characteristics such as non-immunogenicity, 
and enhanced cellular bioavailability are the key issues which 
need to be kept in mind during the engineering of particle 
surface. Such novel approach would serve as a useful alterna-
tive tool for the traditional delivery systems. Thus, the AuNPs 
seem to be an emerging framework for drug and gene delivery 
systems (38).
Applications of nanotechnology for cancer diagnosis 
and therapy
Anti-cancer nanotechnology is a versatile area which 
has potential applications in battling different types of 
cancers, including molecular diagnosis, molecular imaging, 
bioinformatics and targeted drug delivery. The growth of anti-
cancer nanotechnology carries the potential for personalized 
oncology. Thus, it may someday be helpful in such a way 
that protein and genetic biomarkers could be used for the 
diagnosis and treatment of cancer on the basis of molecular 
being extensively researched for their applications in cancer 
diagnosis and treatment. In order to optimize the structures 
therapeutic tools, it is extremely crucial to have understanding 
of their behavior in the tumor microenvironment. Penetration 
and accumulation in the hypoxic centers of cancer cells 
in solid tumors. Whereas, the outer shell of solid tumor is 
Angiogenic blood vessels have gaps of nearly 600 nm. The 
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vascularized regions are liable to be ‘leaky’ and resulting 
in enhanced permeability and retention effects.  Owing to 
their hyperpermeability, tumor cells passively absorb the 
nanoparticles  leading in high concentration (nearly 10-fold 
more) of the carrier in the tumor tissue. Also, the photothermal 
properties of nanoparticles help in the active targeting of the 
molecules and therapeutic agents into the tumor cells (1, 9, 
31, 38, 42-57). 
Cancer diagnosis
The optical properties of AuNPs along with their ability to 
form conjugates have been utilized widely in the diagnosis of 
cancer. Functionalised AuNPs with oligonucleotides, peptides, 
biomolecules have been studied for holding a promising role 
in imaging of cancer cells (42-49). Oligonucleotide conjugated 
AuNPs have been reported for the detection of polynucleotides 
and proteins (like p53, a tumor suppressor gene) with the help 
of various detection methods, for example, gel electrophoresis, 
chronocolormetry, atomic force microscopy, amplified 
voltametric detection, scanometric assay, SPR imaging 
and Raman spectroscopy (1). Gold nanoparticles having a 
isothiocynate (FITC) tag along with folic acid were used to 
target carcinoma cells. Due to the expression of folic acid 
receptors on the HeLa cells, the AuNPs interact only with 
them, thus, providing a sensitive and easy method for detection 
of cancer cells, and differentiating them from non-cancerous 
cells (9, 42, 46-49). 
The various neuroendocrine carcinomas overexpress 
somatostatin receptors. This trait  has been exploited for the 
detection of these carcinomas by use of functionalized AuNPs 
with octreotide peptide, a synthetic analogue of somatostatin. 
The development of bioimaging agents based on the use of 
such receptors can help in tumor diagnosis at an early stage. 
Owing to the increased capacity of recognized as the protein 
functionalized AuNPs show more interaction than the AuNPs 
alone towards the tumor cells (42-49, 58). Likewise, coumarin 
dye and PEG AuNPs show effective internalization into 
the human breast cancer cells. The dual functionalization 
bioimaging and subsequent drug delivery (9, 42-49). 
Monoclonal antibodies (mAb) conjugation has also been 
helpful in the imaging of carcinomas. A PEG modified 
nanoparticle with covalently conjugated mAb Herceptin has 
enabled detection of breast carcinoma. Similarly, other mAb 
can also be used for diagnosis of various cancers (3, 9). 
There are other techniques for visualization of carcinomas, 
including Multiphoton Plasmon resonance microscopy, 
photoacoustic tomography (PAT), third-harmonic microscopy 
and optical coherence microscopy. These are new and 
PAT is a hybrid imaging technique that utilises light for rapid 
heating of elements within the tissue, leading to the production 
of photoacoustic wave (because of thermoelastic expansion) 
generation that can be detected with an ultrasonic transducer. 
The NIR-absorbing gold nanoparticles can significantly 
enhance the image contrast when used in this technique, due to 
the more considerable differences in optical absorption (hence 
generating a stronger photoacoustic wave) than the endogenous 
tissue chromophores. Raman spectroscopy is another but most 
promising imaging technique with respect to gold nanoparticle-
based contrast agent. The SERS nanoparticles consisting of a 
gold core, a Raman-active molecular layer, and an outermost 
silica coating were used for Raman imaging in vivo. Multiple 
SERS nanoparticles with different NIR absorption wavelengths 
can allow concurrent imaging of many tumor markers, and may 
have considerable potential in clinical applications (1).
Cancer therapy
Conventional treatment methods for cancer therapy include 
radiation therapy, chemotherapy and surgery. AuNPs due 
to their unique properties have received most attention for 
cancer therapy (1). The AuNP conjugates have been studied 
for enhancement in outcomes of radiotherapy as well as in a 
light-based therapy against cancer. Use of conjugated AuNPs 
ensures selective destruction of the targeted tumor cells. 
Radiotherapy has been widely used tool for cancer treatment 
in the past with the main objective for destruction of cancer 
cell DNA strands. The goal was achieved through irradiation 
of cancer cells by focussing highly energetic and penetrating 
have a higher probability of absorption of radiation and 
electrons as they contain heavy atoms with a large amount 
of electrons. Photoelectrons have better penetration through 
cells to produce their cytostatic effects. Thus, it provides 
an enhancement to the dose effectiveness of radiation in 
comparison to radiotherapy used solely (59). Unfortunately, 
the normal cells are also adversely affected by radiotherapy.
The local surface plasmon resonance property of AuNPs 
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was explored for therapeutic purposes due to photothermal 
therapy (PTT) of tumor cells and design of light-triggered 
drug delivery (LTDD) system (59). In photothermal therapy, 
upon exposure to NIR light, the AuNPs convert absorbed 
light to heat via electron-electron collision leading to hot 
electrons. This heating effect with the use of AuNPs can cause 
cell death due to the alteration of normal cellular mechanism 
via apoptotic mechanism. A further increase in heating could 
result in cell cycle disruption (10, 11, 16, 59).  There are in 
vitro studies that illustrate the use of various antibodies which 
are capable of producing selective destruction of the targeted 
cell. A comparison amongst the various types of nanoparticles, 
gold nanorods shows optimal light absorption and heat 
and heat transduction. 
Another application of optical properties of AuNPs is 
LTDD. In this system, AuNPs should be capped with agents 
such as biomolecules, polymers, molecular species, etc., 
which can act as reservoirs for the heat-generated release of 
chemotherapeutic drug on irradiation. These cytotoxic drugs 
can be loaded onto the nanoparticles by use of several strategies 
with the drug that either supramolecular or electrostatic, hollow 
nanostructures designed to store drug in them like nanoshells 
and nanocages and insertion of nanoparticles into a highly 
thermosensitive structure like liposomes and temperature 
responsive hydrogels. The best designed photoactive Au-
based nanocarriers is gold nanocage-thermosensitive gel and 
porous-gold-nanoshell-PEG. They are capable of storing large 
amounts of almost any drug molecule and are biologically 
inert. Both of these designs are NIR photoactive, with sizes 
(40 - 60 nm) that allow using the EPR effect to reach the 
tumor cells (59).
Detection of biological molecules
Based on the divergent and unique properties as well as using 
various strategies, AuNPs may  be used for the detection of 
biological molecules like enzymes, DNA, proteins, antigens 
and antibodies (13, 29). The AuNP’s use in detection of 
 
They found that single stranded oligonucleotide targets 
could be detected by use of two dissimilar Au-nanoprobes 
(thiol-linked functionalized oligonucleotide). Each of the 
Au-nanoprobes was functionalized with oligonucleotides that 
were complementary to one of the target oligonucleotide (38). 
Upon introduction of the target into the Au-nanoprobe solution 
resulted in a colour change from red-to-blue. The change 
was due to formation of polymeric network (cross linking 
mechanism), which led to the nanoparticles close enough 
to produce colour change. This method has been expanded 
to a real time screening assay for endonuclease activity. 
Another easy-to-use and inexpensive assay was discovered 
which utilizes an increase in the salt concentration to induce 
aggregation to Au-nanoprobes. Here, the aggregation of Au-
nanoprobes does not result in the presence of complementary 
strands, rather occurs when non-complementary or mismatched 
targets are present. This method was also used in the detection 
of eukaryotic gene expression  without the use of PCR 
 
Another domain for the use of AuNPs is for detection of 
proteins on the basis of their characteristic surface plasmons. 
For this purpose a bifunctional molecule is needed which is 
conjugated to AuNP on one side via thiol conjugation and 
on the other side to electron rich aromatic side of protein 
via diazonium moiety. The nanoparticle acting as a Raman 
marker enhances the vibration of the diazo-bond between the 
protein and the bifunctional molecule. Finally, protein could 
be detected by using surface enhanced Raman spectroscopy. 
Thrombin was used as a protein to test this method (9, 42-49). 
A recent involvement of the Au-nanoprobe cross-linking 
method is a strategy called bio-barcode assay. For the 
detection of proteins it shows attomolar sensitivity, while 
for DNA detection it has zeptomolar sensitivity (18). In this 
method, the analyte either protein or DNA is attached to a 
magnetic microparticle displaying recognition elements. 
Next, it attachs to a functionalised AuNP having a second 
recognition agent and ‘barcode’ DNA strands which are the 
markers, forming a sandwich complex (72). Separation of the 
complex is done by  means of magnetic methods. In the end, 
the DNA barcodes are released and the analyte which is either 
of Au-nanoprobe sandwich assay and scanometric detection 
(using silver enhancement). The conventional bio-barcode 
assays are expensive and laborious, and depending upon 
that utilizes colorimetric, electrochemical, chemiluminescent 
this method has been studied in the detection and measurement 
 (CSF) of 
Alzheimer’s  disease affected patients (72). 
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incorporated poly (vinyl alcohol) 
nanobre
Colon cancer (60)
Indomethacin-eluting stent  Tracheal regeneration (61)
PLGA/collagen with PLGA/drug as 
nano-bre core
 Repairing/healing wounds (62)
Drug-eluting nanobres Contraception (63)
Biodegradable PLGA nano-
brous scaolds with Vancomycin
Brain tissue drug delivery (64, 65)
Biodegradable PLGA nano-
brous scaolds with lidocaine
Epidural space drug delivery applications (66)
Paclitaxel-eluting PCL
nano-brous structure
Benign cardiac stricture (67)
 AuNPs loaded BSA/PVA 
nano-brous scaolds
Cardiac tissue regeneration (68)




dierentiation of mammalian cells, 
enhancing HeLa cell attachment and 
potentiating
cardiomyocyte dierentiation of human 
pluripotent stem cells
(69)
Chitin nano-bers (CNFs) with 
metallic gold nanoparticles 
(AuNPs)
Cosmetic, pharmaceuticals, catalysts, 
electrical, electronic and optical devices.
(70)
Stretchable poly ( -caprolactone) 
(PCL) gold nano particles coated 
force sensors
Hand rehabilitation (70, 71)
Table 1. Biomedical applications of polymeric nanomaterial loaded with AuNPs
Another usefulness of AuNPs has been for the detection of 
A. Vitamin E analogue functionalised with AuNPs via self-
assembly of thiol ligand was used to evaluate the free radical 
against AFB1 functionalised on AuNPs using electro-
deposition on cysteamine functionalized AuNPs were used. 
less response time (9, 46-49).
Detection of microorganisms
AuNPs have been used for the detection bacteria and 
viruses by using various biological, molecular and 
microbiological methods (18, 42-49). An application for the 
use of Au-nanoprobes was for the detection of Microbacterium 
tuberculosis (MTB) and its complex (MTBC). This consists 
of a AuNP-based colorimetric assay which involves 
oligonucleotides conjugated AuNPs. On hybridisation of the 
two probes with their target caused aggregation of AuNPs 
and consequently resulted in change of colour from red to 
blue/purple. 
A similar colorimetric assay was developed for detection 
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of unamplified HCV (define HCV) RNA from clinical 
specimens. After extraction of HCV RNA from the patient 
in a salt containing hybridization buffer. Further, the mixture 
was denatured, annealed, and cooled to room temperature, 
changed its colour to blue if there was aggregation of AuNPs 
in HCV positive specimens, while remained red in the negative 
specimens. There are various other examples for detection of 
microorganisms with the use of AuNPs (18, 47-49). 
AuNP biosensors for detection of disease etiology
An array of biosensors has been developed for basic research 
involved in disease etiology. A nanosensor was used for 
the detection of cholesterol by immobilizing cholesterol 
oxidase on the basis of amperometric changes (9, 42-49, 
73). The nanosensors used were made from gold-platinum 
alloy nanoparticles and showed to have high sensitivity, 
selectivity, fast response and good reproducibility. The 
principle of the detection was based upon hydrogen peroxide 
activity. Further, AuNP can aid detection of uric acid. Uric 
acid is a crucial metabolite of purines and its abnormal levels 
can lead to various metabolic disorders like cardiovascular 
diseases, gout, kidney damage, pneumonia, hyperuriceamia, 
and Lesch-Nyhan syndrome. The detection can be achieved 
by using amperometric methods, which are superior to 
several other methods, including enzymatic, colorimetric and 
electrochemical methods in a way that it can detect uric acid 
in whole blood, serum, and urine with detection limit as low 
as 50 nM (9, 74). Also, AuNPs have been developed for the 
determination of choline in various human samples as well 
as in colorimetric biosensors for the detection of proteinase 
activity assay (9, 43-48).
Several ‘universal’ colorimetric biosensor methods have 
been devised for the detection of a wide range of targets 
including proteins, nucleic acids, DNA, small molecules, and 
water soluble cationic polyelectrolyte are used in this biosensor. 
The colourimetric technique employed in the detection is the 
sequestration of the conjugated polyelectrolyte to ssDNA 
probe that causes aggregation of the AuNPs to produce a 
colour change from red to blue. This happens because the 
polyelectrolyte is not present to stabilise the nanoparticle. 
When a complementary target is present, a weak bond is 
formed between the probe target dsDNA and conjugated 
polyelectrolyte. Now, the polyelectrolyte remains free to 
stabilise the AuNP against aggregation. Target concentration 
can be determined by the use of absorbance ratio. This method 
molecular targets. Thrombin aptamer, anti-cocaine aptamer, 
and a mercury-responsive sequence that folds in the presence 
of Hg (II) were used in this assay for the detection of their 
respective targets (18).
Single nucleotide polymorphisms detection
Single nucleotide polymorphisms (SNPs) detection is also an 
extension of the AuNP’s applications. This method is appropriate 
for the detection of point mutation and polymorphisms in various 
genes associated with diseases and metabolic disorders. The 
individual genetic variability, which is correlated with individual 
mellitus, some cancers and individual responses to therapeutic 
agents. One of the most successful uses of nanoprobes method 
was in the clinical diagnosis of Mycobaterial tuberculosis. 
Another system utilised functionalised AuNP for the detection 
and characterisation of human p53 gene. This technique depicts 
potential for cancer diagnosis (9, 18, 72). 
Immunoassay
AuNPs have been applied in the designing of various 
immunoassays. They have shown potential in the enhancement 
of standard enzyme-linked immunosorbent assays (ELISA) 
signals via conjugation with antibodies or coupling with 
sliver enhancement. Besides ELISA, other techniques such 
as electrochemical methods, conductometery, colorimetry etc. 
have also been used for the detection purposes. AuNPs have 
been studied for the novel enhancement of immunochromato-
graphic strips which increase the detection limit of hCG 
(72). Here, both the primary and the secondary antibodies 
were conjugated to AuNPs. A biochip detection of protein 
was designed using AuNPs and silver enhancement. In this 
procedure antigen is sandwiched in between immobilised 
antibody (antibody immobilised onto the surface of a 
chip with an electrode array using standard micro-electro 
mechanical systems-MEMS technology) and another AuNP 
labelled antibody. On addition of silver enhancement solution, 
reduction of silver ions to metallic silver with hydroquinone 
catalysed by AuNP occurs, followed by deposition of metallic 
silver onto the surface of AuNPs increasing the size of the 
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change in electric conduction and determination of protein 
via conductometric methods (18). 
The new sensing platforms were designed to replace the 
standard ELISA method as they do not demand secondary 
antibody as well as allows increase in sensitivity. The use 
of mono- and poly-clonal antibodies has been replaced by 
the immunosensors utilising single chain fragment variable 
recombinant antibodies (scFv). These scFvs are small 
heterodimers consisting of antibodies with both variable heavy 
(VH) and light (LH) chains linked by a stabilising peptide 
linker. A colorimetric assay was developed with the use of scFv 
functionalised AuNPs having a cysteine or histidine in its linker 
region. The application of AuNPs in another immunoassay is 
under development and is considered to have a great potential 
for future use (9, 75). 
Enzyme immobilisation
Enzyme immobilisation matrices have been made using 
AuNPs. The ability of the AuNPs is utilised to attach and 
functionalise the enzymes, and this process makes the enzymes 
more thermally stable in comparison to the free enzyme. 
Additionally, hollow nanospheres containing active enzymes 
have been synthesised. By this method, enzymes remain active 
for a long period of time and it helps in the detection of small 
molecules which can enter in the nanoshells (9, 43-50). 
CONCLUSION 
The novel development of AuNPs for drug or gene carriers 
and as molecular nanoprobes provides a useful bridging 
tool over the traditional delivery vehicles. AuNPs represent 
an immense scope in biomedical applications due their 
unique properties of high surface/volume ratio, low inherent 
toxicity and surface engineering. The availability of  different 
synthetic methods for creating AuNPs of different sizes and 
shapes bestows a versatile toolbox for the fabrication of 
coherent internalisation, high biocompatibility, enhanced 
permeation into tumor cells, and long circulation half-life 
(t1/2) of conjugates or medicaments. Furthermore, the optical 
and electronic properties of AuNPs are extremely useful for 
monitoring and detecting the biological molecules microbes of 
interest. Recent research on the successful utilisation of AuNPs 
in diagnosis of some diseases and targeted drug delivery 
system has set a platform for the future development of new 
applications in biomedical sciences. Overall, the AuNPs offer 
a bright scope for the diagnosis and treatment of diseases. 
However, there are important issues that need attention such 
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